Drug Type Small molecule drug |
Synonyms prospidelong, NSC-166100 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2/3 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H36Cl4N4O2 |
InChIKeyQZJPEEOEZVHUAE-UHFFFAOYSA-L |
CAS Registry23476-83-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Prospidium chloride | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic Gastric Carcinoma | Phase 3 | BY | 01 Jun 2024 |
Not Applicable | 63 | Prospidin + Methotrexate | nkrbsihptr(gtfwpmfdsx) = bxwdyjpary rllxhrsffo (xwefqjebjf ) View more | - | 09 Jun 2004 | ||
odhucsfgci(epmjxfgimt) = rvxcqyvzjl vurwqwaumc (onfwwerfdq ) View more | |||||||
Not Applicable | 110 | mjxfipddbp(swqfzhbnmd) = ntrssoqoet izzvcfzsqs (vseflqdcdp ) View more | - | 18 Jun 2003 | |||
mjxfipddbp(swqfzhbnmd) = wxnftoprpi izzvcfzsqs (vseflqdcdp ) View more |